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Sports and McArdle Disease 
(Glycogen Storage Disease Type V): 
Danger or Therapy?
Georg Bollig
Abstract
McArdle disease (glycogen storage disease type V) is an inborn error of energy 
metabolism in the muscle. The effects of McArdle disease on physical performance 
have similarities with the metabolic state of marathon runners after glycogen deple-
tion and can therefore be seen as a nature’s experiment in the field of sports medi-
cine. Many patients with McArdle disease avoid sports in general because physical 
activity usually leads to muscle pain and muscle cramps. Often patients therefore 
regard physical activity as both painful and possibly dangerous. This chapter is 
about the advantages and possible risks of sports for patients with McArdle disease. 
The scientific literature will be discussed highlighting both endurance and muscle 
strength exercise. It will discuss the differences of aerobic and anaerobic exercise 
in individuals suffering from McArdle disease. Complications as rhabdomyolysis, 
myoglobinuria, kidney failure, and malignant hyperthermia will be discussed. 
The chapter will summarize the current knowledge about the possible dangers 
versus possible benefits of sports for patients with McArdle disease. A summary of 
recommendations for physical exercise and training for McArdle patients will be 
provided.
Keywords: McArdle disease, glycogen storage disease type V, rhabdomyolysis, 
endurance exercise, muscle strength exercise, aerobic exercise, anaerobic exercise, 
sports medicine
1. Introduction and background
1.1 No sports?
Many people with McArdle disease do not like sports or physical activity and say 
therefore no to participation in sports activities or regular physical exercise. The 
aim of this chapter is to address patients and health care providers’ queries about 
vMcArdle disease and sports as well as to provide guidance on physical activity for 
those who have to live with McArdle disease.
McArdle disease (glycogen storage disease type V) is an inborn error of energy 
metabolism in the muscle [1–5]. It hampers physical exercise in affected patients 
due to the restriction of the availability of glucose as energy source for muscular 
work. It can be seen as a nature’s experiment in the field of sports medicine as the 
underlying defect of the myophosphorylase enzyme leads to metabolic effects 
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that are similar to the effects of glycogen depletion in marathon runners [2]. Many 
patients with McArdle disease (McAd) avoid sports because physical activity 
usually leads to muscle pain and muscle cramps. Often patients with McAd there-
fore regard physical activity as both painful and dangerous. On the other hand, 
physical activity is of great importance to manage daily life. Living is based on 
regular motion, and muscles have to be used in order to be healthy. Not using our 
muscles will in the long run lead to weakness, immobility, and frailty. Therefore 
people affected by McArdle disease do benefit of keeping a certain degree of fitness. 
Regular physical exercise might play a key role in delaying progressive muscle wast-
ing, weakness, and frailty in later life of people affected by McAd.
• But how much physical activity is beneficial and what might be dangerous?
• Are certain types of physical exercise better than others?
These and many other questions arise when talking about physical activity and 
sports with patients with McAd. People with McAd do therefore need guidance on 
physical activity based on scientific and evidence-based facts. Due to unpleasant 
experience with sports in the form of pain, cramps, weakness, or myoglobinuria, 
many patients with McAd show a tendency to avoid sports and physical activ-
ity because they are afraid that sports may be not only painful but also harmful. 
Unfortunately this behavior can decrease their physical activity and physical capac-
ity further. This chapter will shed light on McArdle disease and sports in general 
and try to answer the above mentioned questions.
2. Method
This chapter is based on a review of the existing publications on McArdle disease 
(glycogenosis type V) and sports and the authors’ personal experience with the 
topic based on his German PhD thesis on the subject [2] and practical experience 
with patients with McArdle disease from sports medicine and anesthesiology. A 
literature search with the Medical Subject Heading (MeSH) words “McArdle dis-
ease” and “sports” was performed using the search engines PubMed and Medline. 
Publications that had McArdle disease and sports as a topic were included. In 
addition reference lists of books and other sources were assessed by hand search. An 
overview of the existing literature on this topic is provided.
3. McArdle disease: a nature’s experiment
McArdle disease was first described in 1951 by Brian McArdle, a British neurologist. 
It is known by different synonyms as myophosphorylase insufficiency, glycogen storage 
disease type V, or myophosphorylase deficiency [1–5]. Table 1 provides an overview 
of the different types of glycogen storage diseases [6]. McArdle disease is caused by a 
lack of myophosphorylase (alpha-1,4-glucan orthophosphate glycosyl transferase) that 
normally initiates muscle glycogen breakdown during exercise by removing 1,4-gly-
cosyl groups from the glycogen molecule leading to the release of glucose-1-phosphate 
[1–5] and thus providing fuel for muscular work. Patients with McAd are unable to use 
the glycogen storage in the muscles as an energy source to enable physical activity.
In about 50% of patients with McAd, a positive family history can be found. For 
most of the patients, the diagnosis is first established between the age of 10 and 
30 [3]. The disease is described to be autosomal recessive, although transmission 
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clinically appears to be autosomal dominant in some affected families [2–4, 7]. The 
gene for myophosphorylase lies on chromosome 11q13. There are a number of dif-
ferent mutations described in the scientific literature; the most frequent mutation is 
named R50X [5].
The prevalence of McArdle disease is not known exactly due to the relative 
benign course of the disease and the often mild and frequently misinterpreted 
clinical symptoms. The clinical symptoms are summarized in Table 2. Haller has 
estimated the prevalence of McArdle disease in the Dallas-Fort Worth region as 1 in 
100,000 [8].
As the pathophysiological effects of McAd are similar to the state of glycogen 
depletion in marathon runners, it is of special interest from the view of sports 
medicine and has been called a nature experiment [2].
Type of 
glycogen 
storage 
disease
Enzyme defect Inheritance Organs 
involved
Clinical symptoms
Type 0 Glycogen synthase 
deficiency
Liver Fasting hypoglycemia, 
tiredness, pallor, 
vomiting, muscle cramps
Type I Von 
Gierke 
disease
Glucose-6-phosphatase 
deficiency
Autosomal 
recessive
Liver, 
kidney
Growth retardation, 
hypoglycemia
Type II 
Pompe 
disease
Acid maltase deficiency Autosomal 
recessive
Muscle, 
heart, 
liver
Hypotonia, muscle 
weakness (progressive), 
affected: proximal and 
respiratory muscle, 
cardiac enlargement and 
failure
Type III 
Cori disease
Debrancher enzyme 
deficiency
Autosomal 
recessive
Liver, 
muscle, 
heart
Growth retardation, 
muscle weakness (liver 
cirrhosis can occur)
Type IV 
Andersen 
disease
Branching enzyme 
deficiency
Autosomal 
recessive
Liver, 
kidney, 
heart, 
muscle
Mild hypoglycemia
Type V 
McArdle 
disease
Myophosphorylase 
deficiency
Autosomal 
recessive
Skeletal 
muscle
Exercise intolerance, 
muscle cramps and 
pain, myoglobinuria on 
strenuous exercise
Type VI 
Hers disease
Liver phosphorylase 
deficiency
Autosomal 
recessive
Liver Mild hypoglycemia
Type VII 
Tarui 
disease
Phosphofructokinase 
deficiency
Autosomal 
recessive
Skeletal 
muscle
Muscle pain and fatigue 
on exercise. Muscle 
cramps and tenderness
Type VIII Phosphorylase b kinase 
deficiency
X-linked 
recessive
Liver, 
brain
Ataxia, spasms, brain 
degeneration
Type IX Phosphoglycerate kinase 
deficiency
X-linked 
recessive
Liver Mild hypoglycemia
Type X Phosphoglycerate mutase 
deficiency
Autosomal 
recessive
Liver, 
muscle
Exercise intolerance, 
muscle pain
Table 1. 
Overview of glycogen storage diseases (modified from [6]).
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4. Typical clinical picture and diagnosis of McArdle disease
4.1 Typical clinical picture
Typical clinical symptoms of McArdle disease are muscle pain and fatigue dur-
ing exercise. Pain is often located in the knee, calf, and legs. Normally pain vanishes 
after a few minutes rest. Clinical symptoms and signs are shown in Table 2 [1–4].
4.2 Diagnosis of McArdle disease
Diagnosis is based on the clinical picture, muscle biopsy, biochemical tests, 
exercise testing, and genetic testing [2–4, 7, 9] as listed in Table 3.
The absence of rising lactate is a diagnostic criterion in McAd. Usually this has 
been tested using the forearm ischemic exercise test [2–4]. Both Bollig [2] and 
Vissing and Haller [9] have suggested to use cycle ergometry testing instead of the 
forearm ischemic exercise test. The ischemic forearm exercise is more painful for 
the patients and might put them at risk for severe rhabdomyolysis and myoglobin-
uria. The cycle ergometry as diagnostic tool from sports medicine is useful in the 
diagnosis of McAd and may be used to assess the actual state of cardiopulmonary 
fitness and may help to give patients guidance for further training. Figure 1 shows 
the results of cycle ergometry testing in a typical patient with McArdle disease [2].
• Muscle pain (myalgia)
• Fatigue
• Cramps
• Exercise intolerance
• Intermittent claudication
 ○ (Muscle pain on mild exertion in the calf muscle, usually attributed to peripheral artery disease)
• Second wind phenomenon
• (Exercise becomes easier after a period of moderate and tolerable exercise)
• Stiffness
• Muscle swelling after exercise
• Myoglobinuria
• Muscular atrophy
• (Mostly proximal muscles affected and in elderly patients)
Table 2. 
Clinical symptoms and signs of McArdle disease [1–4].
• Clinical picture
• Elevated creatine kinase (CK) levels in the blood
• Absence of increased venous lactate during forearm ischemic exercise test or cycle ergometry
• Low or absent myophosphorylase activity on histochemical or biochemical examination of muscle 
biopsy
• Genetic testing (the muscle phosphorylase gene is located on chromosome 11q13, and several mutations 
have been described—the most common mutation is called R50X)
Table 3. 
Diagnosis of McArdle disease [2–4, 7, 9, 10].
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The prognosis of McArdle disease is usually good, and life expectancy is normal 
although severe cases with muscle wasting and extreme weakness and death in 
childhood have been described [1–4, 10].
5. Treatment options
At present there are no causal treatment options available. Some symptomatic 
treatment options may reduce symptoms or enhance the amount physical activity 
that can be tolerated. These treatment options include oral sucrose before exercise 
[11], a low dose of oral creatine [12], vitamin B6 [2, 10], and coenzyme Q10 [2, 10]. 
Our study about the use of clenbuterol over a 12-month period leads to a subjective 
improvement of exercise tolerance in three patients. Some relatives of the patients 
noted an improved exercise tolerance after clenbuterol intake over some weeks 
[2]. One patient from our study has used a low-dose clenbuterol (0.005–0.02 mg 
once daily) to enhance exercise tolerance for more than 10 years. This patient used 
clenbuterol for some months with regular breaks of weeks up to months between the 
therapy cycles. A systematic Cochrane review on pharmacological and nutritional 
treatment options has been published by Quinlivian et al. [12]. There do exist animal 
models for McArdle disease in sheep, cows, mice, and rats that may be used to test 
potential therapies in future studies [10]. Gene therapy of McArdle disease might be 
a future option, but its dangers outweigh the possible advantages at present [10].
6. Health problems and possible risks associated with McArdle disease
Patients with McArdle disease are at risk of developing myoglobinuria and even 
kidney failure due to rhabdomyolysis after exercise or anesthesia [2, 3, 12, 13]. 
Therefore, patients affected by McAd should learn how to accomplish daily activity 
Figure 1. 
Cycle ergometry of patient F.M., born 1967, 183 cm, 80 kg; modified from [2].
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with McAd and how to avoid major muscle damage and the risk for massive rhabdo-
myolysis and acute kidney failure.
Some cases with insulin resistance and a diabetes type II-like clinical picture 
in patients with McArdle have been described, but there is no known connection 
between type I diabetes and McArdle disease [10]. Increased glycogen storage in 
the muscle of McArdle patients has been suggested as a probable cause of insulin 
resistance in McArdle patients [10]. Overweight has been observed in many patients 
with McAd [14]. This might be a potential risk factor for developing type II diabetes 
as it is for other people without McArdle disease.
Another potential problem is the possible risk of malignant hyperthermia which 
is a complication during general anesthesia associated with different muscular 
diseases. Although no case of malignant hyperthermia during anesthesia has been 
described in McAd so far, it is a potential risk when patients with McAd have to 
undergo operations with the need for general anesthesia. Therefore, precautions 
have to be taken by the anesthesiologist, and local or regional anesthesia may be 
preferred whenever feasible [6, 13].
7.  Effects of physical activity and sports in patients  
with McArdle disease
As described above patients with McAd might suffer from exercise intoler-
ance and pain, fatigue, and cramps during exercise, typical clinical symptoms 
of McArdle disease. Up to 50% of the patients with McAd show myoglobinuria, 
and unfortunately acute renal failure has been described in 27% following rhab-
domyolysis as a result of vigorous or strenuous exercise [3]. Cases with extreme 
rhabdomyolysis and myoglobinuria have, e.g., been reported after a swimming 
competition, an asthma attack, after carrying a TV, and after the diagnostic use of 
the ischemic work test using a tourniquet [15–19]. The variation of creatine kinase 
(CK) levels in the blood has been investigated in a male with McAd over a period 
of several months by the author [2]. Figure 2 shows the results from this German 
doctor thesis from the year 2000. The results indicated that anaerobic exercise 
and physical activity demanding great strength or strenuous exercise lead to huge 
increases in creatine kinase activity, whereas aerobic exercise did not increase blood 
creatine kinase levels to a great extent. Aerobic exercise was shown to be associated 
with lower creatine kinase levels after physical activity in a number of instances 
during the study period [2, 20]. This finding was later proofed by other researchers 
[10]. The oxygen uptake and physical ability of patients affected by McAd is usually 
limited to about 50% of comparable healthy individuals [2].
7.1 The second wind phenomenon
The second wind phenomenon is defined as “a period of less painful and more 
effective exercise associated with a decrease in heart rate after the initial period of 
cramping and/or weakness.” [21]. Many patients with McArdle disease do experience 
this phenomenon that was first described by Pearson et al. [22]. During exercise this 
phenomenon can lead to better endurance because patients are able to exercise for a 
longer period and experience physical activity as less painful in the long run.
7.2 Aerobic exercise (endurance exercise)
Aerobic exercise is endurance exercise where oxygen is needed in energy pro-
duction. Aerobic energy production takes some minutes to start but can help to 
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supply energy for muscular activity over a longer period of time (several minutes 
up to several hours). Due to the lack of glucose that cannot be released from the 
glycogen deposits in the muscle, patients with McArdle disease rely on fatty acids, 
amino acids, and glucose from the liver as energy source during exercise [2, 10]. 
These mechanisms are based on aerobic metabolism. Patients with McAd can 
therefore tolerate longer periods of physical activity well if it is aerobic exercise of 
mild-to-moderate intensity. The work intensity that patients with McAd do tolerate 
can show big variations between different patients.
During the study period, different types of physical activity were recorded in a 
diary by the patient. Aerobic exercise as cycling and walking/hiking did not lead to 
CK elevation, whereas anaerobic exercise leads to CK elevation.
Different researchers have recommended aerobic training and aerobic con-
ditioning in order to improve physical activity, oxygen uptake, cardiovascular 
fitness, and energy supply via the blood in McAd [2, 10, 23–26]. Especially walking 
and cycling with mild or moderate intensity can be recommended for all McAd 
Figure 2. 
Creatine kinase levels from a long-term follow-up over 5 months [modified from [2]].
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patients to improve their physical capacity [2, 10, 25–27]. Aerobic metabolism 
usually starts after 7–10 min of exercising. Therefore, patients with McAd should 
warm up with low intensity and may increase the intensity of physical work after 
7–10 min. Some of the patients experience the above described second wind 
phenomenon.
7.3 Anaerobic exercise
During anaerobic exercise (within the first seconds and minutes or using 
great strength), energy is supplied by anaerobic mechanisms as anaerobic 
glycogenolysis without oxygen. Short periods of activity with high intensity 
such as running, walking upstairs, and carrying or lifting heavy weights require 
anaerobic metabolism. Due to the deficiency of the myophosphorylase enzyme 
in the muscle of McAd patients, this is hampered. Anaerobic physical activity 
can thus lead to muscular damage in patients with McAd and should be avoided 
as far as possible by patients with McAd [2, 10, 25]. Nevertheless supervised 
resistance training has been shown to improve muscle strength in patients with 
McAd [28]. Pietrusz et al. state that strength training for McArdle patients 
is safe when it is tailored to the patient as “short bursts of resistance activity 
lasting no longer than 10 seconds preceded and followed by 30 seconds to 3 
minutes rest.” In a case report of two McAd patients, an improvement of both 
muscular strength and quality of life was observed after a period with resis-
tance training [29].
8. Discussion and conclusions
Sport is the most important therapeutical option for patients with McArdle 
disease. Aerobic conditioning can be recommended to all McAd patients, but 
anaerobic exercise may lead to muscular damage. It has been shown by different 
researchers that regular physical activity may lead to improved exercise capacity 
[2, 10, 23–26]. As we have learned from practical experience and the scientific 
literature, extensive physical and strenuous exercise may lead to muscle damage, 
myoglobinuria, and even acute kidney failure [15–19]. Nevertheless Santalla et al. 
and Pietrusz et al. have shown that resistance training under expert supervision 
is feasible and improves muscle strength in McArdle patients. But it is important 
that this type of training is performed under supervision in order to avoid muscle 
damage [28, 29]. On the other hand, a case study with a long-term follow-up of 
one patient with McAd has shown that mostly aerobic activity did not lead to an 
increase in the creatine kinase level. Instead, moderate cycling or hiking led to a 
decrease in the creatine kinase [2]. In the same patient, anaerobic exercise lead to 
increased CK levels suggesting muscle damage after carrying heavy weights [2]. 
In order to avoid muscle damage by vigorous exercise or in a risky way, all patients 
with McAd should receive sport medical advice on an individualized training 
plan that meets their individual training needs. In order to enhance patient 
compliance, common aims and routines for physical activity and sports should be 
established.
In conclusion, regular activity and sport are paramount for patients with 
McArdle disease. Patients benefit from regular physical activity. Sport should be 
based on aerobic conditioning such as walking and cycling, whereas anaerobic 
exercise of high intensity over short periods should be avoided in general. Physical 
activity must be individualized to the patients’ capacity and needs. Some case 
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reports suggest that even resistance training might be feasible, effective, and safe 
for patients with McAd. Obviously there is individual variation of the intensity that 
is appropriate for different patients. Therefore, a cooperation with a doctor expe-
rienced on sports medicine, trainer, and physiotherapist can help to establish an 
individualized training plan in order to maintain and possibly to improve physical 
capacity without increasing the danger for undesirable effects of too much physical 
activity.
Probably a self-monitoring of the CK blood level (like measuring blood-glucose 
in diabetes patients) could help to guide training and individual response to exer-
cise in the future. More research on specially designed training programs for McAd 
is needed.
The following general recommendations shown in Table 4 are based on per-
sonal experience of the author and the current state of the scientific literature  
[2, 10, 20–30].
As shown above, sport has therapeutic potential for people with McArdle 
disease. Sport is used with reason and is therefore not a danger but a powerful 
medicine.
Conflict of interest
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• Do not be afraid of physical activity.
• Individualize your personal training goals.
• Compete with yourself and not with others.
• Aerobic conditioning (walking or cycling) is the preferable training method for patients with McAd.
• Keep on doing physical activity on a regular basis three to five times a week using aerobic exercise, such 
as walking or cycling for about 30–40 min on each occasion.
• Regular training of mild-to-moderate intensity will improve physical capacity and may postpone weak-
ness and muscle wasting in elderly patients.
• Preexercise nutrition may enhance physical performance.
• Resistance training should only be used under competent supervision of physicians and/or physiothera-
pists with experience in treating McArdle patients in order to avoid muscle damage.
Table 4. 
Recommendations for physical activity for patients with McArdle disease.
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